Narrative Update • Jul 10
Have your own idea? Try our Stock Screener
Japanese (NIKKEI) Biotech Industry Analysis
UpdatedJul 12, 2026
DataAggregated Company Financials
Companies35
- 7D-2.5%
- 3M-22.9%
- 1Y-28.4%
- YTD-15.9%
Over the last 7 days, the Biotech industry has dropped 2.5%, driven by a pullback from GNI Group of 8.9%. Meanwhile, AnGes actually outperformed within the industry, gaining 8.5% in the last week. However, the industry is down 28% over the past year. As for the next few years, earnings are expected to grow by 39% per annum.
Industry Valuation and Performance
Has the Japanese Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 13 Jul 2026 | JP¥848.0b | JP¥159.3b | -JP¥44,566,762,682.00 | 29.6x | -19x | 5.3x |
| Wed, 10 Jun 2026 | JP¥991.9b | JP¥198.8b | -JP¥57,269,138,682.00 | 48.9x | -17.3x | 5x |
| Fri, 08 May 2026 | JP¥1.1t | JP¥202.7b | -JP¥49,543,646,682.00 | 60.7x | -22.8x | 5.6x |
| Sun, 05 Apr 2026 | JP¥1.1t | JP¥202.7b | -JP¥49,292,644,682.00 | 56.5x | -22.9x | 5.6x |
| Tue, 03 Mar 2026 | JP¥1.3t | JP¥200.5b | -JP¥50,373,794,682.00 | 322.6x | -25.3x | 6.4x |
| Thu, 29 Jan 2026 | JP¥1.1t | JP¥198.7b | -JP¥70,406,297,000.00 | 60.5x | -15.1x | 5.4x |
| Sat, 27 Dec 2025 | JP¥978.5b | JP¥198.7b | -JP¥70,727,387,000.00 | 52.7x | -13.8x | 4.9x |
| Mon, 24 Nov 2025 | JP¥1.1t | JP¥196.3b | -JP¥69,252,365,000.00 | 52.3x | -15.2x | 5.4x |
| Wed, 22 Oct 2025 | JP¥1.1t | JP¥197.7b | -JP¥65,502,224,000.00 | 64.3x | -17.2x | 5.7x |
| Fri, 19 Sep 2025 | JP¥1.2t | JP¥197.7b | -JP¥65,794,561,000.00 | 64.9x | -17.6x | 5.9x |
| Sun, 17 Aug 2025 | JP¥1.2t | JP¥193.5b | -JP¥68,256,278,000.00 | 119.2x | -17.6x | 6.2x |
| Tue, 15 Jul 2025 | JP¥1.1t | JP¥218.2b | -JP¥43,671,220,000.00 | 100.1x | -25.6x | 5.1x |
| Thu, 12 Jun 2025 | JP¥1.3t | JP¥216.3b | -JP¥43,035,705,000.00 | 92.7x | -29.2x | 5.8x |
| Sat, 10 May 2025 | JP¥1.1t | JP¥207.8b | -JP¥39,324,850,000.00 | 14.6x | -27x | 5.1x |
| Mon, 07 Apr 2025 | JP¥935.2b | JP¥207.7b | -JP¥39,165,298,000.00 | 14.3x | -23.9x | 4.5x |
| Wed, 05 Mar 2025 | JP¥1.0t | JP¥207.4b | -JP¥38,725,942,000.00 | 15.2x | -26.3x | 4.9x |
| Fri, 31 Jan 2025 | JP¥1.0t | JP¥207.3b | -JP¥13,514,452,000.00 | 20.6x | -74.1x | 4.8x |
| Sun, 29 Dec 2024 | JP¥1.1t | JP¥206.4b | -JP¥12,718,356,000.00 | 22.2x | -85.2x | 5.2x |
| Tue, 26 Nov 2024 | JP¥1.1t | JP¥207.5b | -JP¥11,044,446,000.00 | 21.3x | -97.9x | 5.2x |
| Thu, 24 Oct 2024 | JP¥1.1t | JP¥214.3b | -JP¥3,941,502,000.00 | 21.5x | -274.6x | 5.1x |
| Sat, 21 Sep 2024 | JP¥1.1t | JP¥214.3b | -JP¥2,078,229,000.00 | 20.2x | -542.2x | 5.3x |
| Mon, 19 Aug 2024 | JP¥998.6b | JP¥210.0b | -JP¥801,432,000.00 | 13.7x | -1246x | 4.8x |
| Wed, 17 Jul 2024 | JP¥1.1t | JP¥187.7b | -JP¥15,872,047,000.00 | 95.5x | -67.7x | 5.7x |
| Fri, 14 Jun 2024 | JP¥882.4b | JP¥193.8b | -JP¥15,007,284,000.00 | 97.8x | -58.8x | 4.6x |
| Sun, 12 May 2024 | JP¥796.4b | JP¥199.1b | -JP¥14,542,545,000.00 | 78.6x | -54.8x | 4x |
| Tue, 09 Apr 2024 | JP¥761.4b | JP¥194.2b | -JP¥15,457,837,000.00 | 65x | -49.3x | 3.9x |
| Thu, 07 Mar 2024 | JP¥815.9b | JP¥196.2b | -JP¥19,179,997,000.00 | 62.5x | -42.5x | 4.2x |
| Sat, 03 Feb 2024 | JP¥744.0b | JP¥222.4b | -JP¥12,442,827,000.00 | 17.5x | -59.8x | 3.3x |
| Mon, 01 Jan 2024 | JP¥814.6b | JP¥222.3b | -JP¥12,668,455,000.00 | 17.6x | -64.3x | 3.7x |
| Wed, 29 Nov 2023 | JP¥790.6b | JP¥221.9b | -JP¥12,426,487,000.00 | 17.1x | -63.6x | 3.6x |
| Fri, 27 Oct 2023 | JP¥736.6b | JP¥223.0b | -JP¥14,478,735,000.00 | 20.8x | -50.9x | 3.3x |
| Sun, 24 Sep 2023 | JP¥852.4b | JP¥223.0b | -JP¥14,518,735,000.00 | 27.5x | -58.7x | 3.8x |
| Tue, 22 Aug 2023 | JP¥850.3b | JP¥225.1b | -JP¥19,814,131,000.00 | 47.9x | -42.9x | 3.8x |
| Thu, 20 Jul 2023 | JP¥916.4b | JP¥223.0b | -JP¥19,224,669,000.00 | 48.9x | -47.7x | 4.1x |
Price to Earnings Ratio
-47.7x
Current Industry PE
- Investors are relatively neutral on the Japanese Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 4.9x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Revenues have also declined 11% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the Japanese Healthcare industry?
| JP Market | -0.89% | |
| Healthcare | -1.39% | |
| Biotech | -2.48% | |
| Biotech | -2.48% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 4563 AnGes | JP¥51.00 | 8.5% +JP¥1.6b | -16.4% | PS22.4x | |
| 4593 Healios K.K | JP¥261.00 | 4.4% +JP¥1.5b | -49.5% | PS476.2x | |
| 4575 CanBas | JP¥758.00 | 9.9% +JP¥1.3b | -27.3% | PB7x | |
| 7774 Japan Tissue Engineering | JP¥646.00 | 5.2% +JP¥1.3b | -2.0% | PS12x | |
| 4894 Cuorips | JP¥4.81k | 3.2% +JP¥1.2b | -22.2% | PS187.2x |